May 10, 2023 NGS, NGS, NGS, Oncology, Pathology, Urology Bladder cancer: Bladder by NGS Learn more By Mario Fonte 0
December 13, 2020 Oncology, Other methodologies, Other methodologies, Pathology ENCITOG72 Breast cancer: amplification of FGFR1 (8p12) and FGFR2 (10q26) genes, in paraffin Learn more By Mario Fonte 0
December 12, 2020 Oncology, Other methodologies, Other methodologies, Pathology ENTS32 Breast cancer: PIK3CA Learn more By Mario Fonte 0
August 12, 2020 Gastroenterology, Oncology, Other methodologies, Other methodologies, Other methodologies, Pathology ENTS11 Colorectal cancer: BRAF (Val600) Learn more By Mario Fonte 0
December 12, 2020 Gastroenterology, NGS, NGS, NGS, Oncology, Pathology ENTS30 Colorectal cancer: CCR by NGS Learn more By Mario Fonte 0
August 12, 2020 Gastroenterology, Oncology, Other methodologies, Other methodologies, Other methodologies, Pathology ENTS9 Colorectal cancer: KRAS, NRAS and BRAF (Val600) Learn more By Mario Fonte 0
April 29, 2021 Gastroenterology, Oncology, Other methodologies, Other methodologies, Other methodologies, Pathology ENTS35 Colorectal cancer: MLH1 promoter hypermethylation Learn more By Mario Fonte 0
August 12, 2020 Gastroenterology, Oncology, Other methodologies, Other methodologies, Other methodologies, Pathology ENTS12 Colorectal cancer: MSI (Microsatellite Instability) Learn more By Mario Fonte 0
April 29, 2021 Oncology, Other methodologies, Other methodologies, Pathology ENTS34 Endometrial cancer: MLH1 promoter hypermethylation Learn more By Mario Fonte 0
April 28, 2021 Oncology, Other methodologies, Other methodologies, Pathology ENTS33 Endometrial cancer: POLE Learn more By Mario Fonte 0
